A detailed history of Dunhill Financial, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Dunhill Financial, LLC holds 664 shares of BMY stock, worth $38,067. This represents 0.02% of its overall portfolio holdings.

Number of Shares
664
Previous 475 39.79%
Holding current value
$38,067
Previous $19.7 Million 74.18%
% of portfolio
0.02%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 15, 2024

BUY
$39.66 - $51.75 $7,495 - $9,780
189 Added 39.79%
664 $34.4 Million
Q2 2024

Aug 09, 2024

BUY
$40.25 - $52.99 $9,217 - $12,134
229 Added 93.09%
475 $19.7 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $1,391 - $1,577
29 Added 13.36%
246 $13.3 Million
Q4 2023

Feb 12, 2024

BUY
$48.48 - $57.85 $10,520 - $12,553
217 New
217 $11.2 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $122B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Dunhill Financial, LLC Portfolio

Follow Dunhill Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dunhill Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Dunhill Financial, LLC with notifications on news.